Message from Chairman

The history of Tianjin Institute of Pharmaceutical Research (TIPR) for more than 60 years is the epitome of the development of new China’s pharmaceutical industry. As time goes on, TIPR has become an important member in the health industry of China Merchants Group, and is still flourishing, walking more and more firmly and confidently on the road of pharmaceutical innovation.

Innovation is the spirit of Tianjin Institute of Pharmaceutical Research. From the “Vitamins, Antibiotics, Hormones and Sulfonamides”, which filled the gap of Chinese medicine, to the first dripping pills “Suxiao Jiuxin Pill”, the first soft capsule preparation “Maren Soft Capsules”, the first Class II new drug “Indapamide”, and the exclusive product “Agatroban” and “Adefovir”, more than 200 new drug certificates are the achievements of the continuous pursuit of innovation by the generations of TIPR.

Reform is the main line of innovation and development of Tianjin Institute of Pharmaceutical Research. The development of TIPR experienced three important stages, from a central government-affiliated institution, to a state-owned enterprise in Tianjin, to a mixed-ownership enterprise belonging to a central enterprise. TIPR has blazed a development path with its own distinctive characteristics by keeping innovation according to the development of the times.

Struggle is the heritage of the enterprise spirit of TIPR. “Revitalizing the pharmacy through science and technology is for the good of all mankind” is the original intention and mission of TIPR, and it is the responsibility and motivation for generations of scientists and technicians to make continuous progress in scientific and innovative achievements. Contributing new drugs and good drugs to the society and applying the technology and products to the motherland is the greatest value we can achieve.

Entering a new era and standing at a new starting point, Tianjin Institute of Pharmaceutical Research  reinvigorated to achieve the dream of “A hundred years of TIPR, international TIPR” and to help achieve a strong pharmaceutical country and a healthy China!

Company Profile

Tianjin Institute of Pharmaceutical Research (TIPR), as one of the nation’s most important institutes, has a history of over half a century and has been engaged in pharmaceutical research and development. Today it has grown from an academic research institute up to a comprehensive high-tech pharmaceutical enterprise integrating scientific research, manufacture and sales. The scientific research of TIPR covers the fields of drug synthesis, pharmaceutical preparations, Chinese medicine pharmacy, modern biological pharmaceutical, pharmacological drug, drug safety evaluation, drug analysis and medical information. With advanced talents and relying on the State Key Laboratory as well as other professional platforms, TIPR pays special attention to the engineering and industrialization of new technology. Meanwhile it meets all kinds of new drug registration requirements. Its technologies in the fields of drug metabolism and pharmacokinetics, safety evaluation and new preparation are in the leading positions in China.

TIPR possesses independent industrial and technical service platforms to promote the transfer of research achievements. We are composed of TIPR Pharmaceutical Co., Ltd.(holding controlled) , TIPR Drug Assessment Co., Ltd. (holding controlled), TIPR-HUYA AIM Co., Ltd. and other pharmaceutical enterprises. For over 50 years, TIPR has carried out fruitful cooperation with pharmaceutical companies all over the country, which not only provides a large number of excellent new medicinal products for the society, but also produces many outstanding enterprises.

With a comprehensive research mechanism and a professional talent team, TIPR has been continuously offering new products and technologies by maintaining close observation of the changes and trends of the pharmaceutical industry. In addition to developing new and excellent pharmaceutical products, TIPR has also brought generous economic returns to our partners. With our comprehensive and professional technical service, TIPR is committed to promoting the upgrading of your products and making your dream come true.

History

1959 – Tianjin Institute of Pharmaceutical Research was set up.

1987 – Three predecessor units converged into Tianjin Institute of Pharmaceutical Research.

2000 – Tianjin Institute of Pharmaceutical Research received localized management from an institution to an enterprise owned by the whole people.

2018 – another important time node in the development history of Tianjin Institute of Pharmaceutical Research. Taking the historical opportunity of mixed-ownership reform, Tianjin Institute of Pharmaceutical Research took the initiative to reform and became an important platform of China Merchants Group in the health industry. Tianjin Institute of Pharmaceutical Research is committed to creating the “world’s influential and China’s first-class” R&D-based pharmaceutical enterprises and becoming a “centennial world institute”.

Corporate Culture

Corporate vision: To become a top R & D pharmaceutical company in China with world influence

Corporate mission: Benefit the medical industry and the mankind with science and technology

Core values: Share your destiny with the motherland and develop with the times

Enterprise spirit: Integrity  Friendliness  Innovation  Dedication

Enterprise philosophy: People-first and equal attention to research and business

Cultural atmosphere: Simple  Sunny  Solerant

Board of Directors

Yadong Li  Chairman

Current general manager assistant of China Merchants Group, part-time Chairman of China Merchants HOI TUNG Trading Company Limited., China Merchants Health Industry Holding Co., Ltd. and Tianjin Institute of Pharmaceutical Research Co., Ltd.

MBA of China Europe International Business School, Bachelor in Administrative Information Management of Renmin University of China

Xiaoguang Li  Deputy Chairman

Current Vice-general Manager of Tianjin Tsinlien Investment Holdings Co., Ltd.; part-time Deputy Managing Director of Tianjin Development Holdings Co., Ltd , part-time Chairman of Tianjin Institute of State-owned Assets, and part-time Deputy Chairman of Tianjin Institute of Pharmaceutical Research Co., Ltd.

Former director and general manager assistant of Tianjin Tsinlien Investment Holdings Co., Ltd; Former general manager of Enterprise Development Department in Hong Kong Tsinlien Group Co., Ltd.

Doctorate in World Economics of Institute of International Economics, Nankai University.

.

Lida Tang  Deputy Chairman

Expert with special government allowance of the State Council

Current Secretary of the Party Committee and chief scientist of Tianjin Institute of Pharmaceutical Research Co., Ltd.

Former Chairman and president of Tianjin Institute of Pharmaceutical Research Co., Ltd.

Doctorate in Organic Chemistry of Shandong University, Master of Medicine in Academy of Military Medical Sciences.

Shixin Yu  Director

Current Director of Health Industry Department of China Merchants Group Co., Ltd., part-time General manager and secretary of the party committee of China Merchants HOI TUNG Trading Company Co., Ltd.

Former General Manager of China Communication Import & Export Co., Ltd., former General Manager of China Merchants Bonded Logistics Co., Ltd., former Vice-general Manager and Discipline Inspection Commission Secretary of China Merchants Holdings (International)  Company Limited.

MBA in China Europe International Business School, Master of University of International Business and Economics.

Ping Zhang  Director

Current party committee member and Vice-general Manager of Tianjin Pharmaceutical Group Co., Ltd.; part-time Chairman of Tianjin MEDA Medical Technology Co., Ltd., part-time director of Tianjin Zhongxin Pharmaceuticals Co., Ltd., former director of Tianjin Institute of Pharmaceutical Research Co., Ltd.

Former standing committee member, director and chief engineer of Tianjin Pharmaceutical Group; former party committee member, director, Vice-general Manager, chief engineer and general counsel of Tianjin Zhongxin Pharmaceuticals Co., Ltd.; former member and deputy district mayor of Ninghe District, Tianjin; former standing committee member and subprefect of Qamdo, Tibet.

Doctor of Management in Nankai University, Master of Management in Tianjin University of Finance & Economics, Bachelor of Chemical Medicine in East China University of Science and Technology.

En Tao Director

Current executive director of China Merchants Capital Investment Limited., COO of Jingzhou Merchants Huide Capital Management Co., Ltd.

Former executive director of FOUNDER H Fund Limited., former strategic investment manager of Hudson Bay Trading Company (HBTC).

MBA in York University, Bachelor of Computer in East China University of Science and Technology

Yang Yu  Director

Current director of Risk Control Department in Tianjin Tsinlien Investment Holdings Limited. Part-time director of Risk Control Department in Tsinlien Group Limited. and Tianjin Development Holdings Limited., part-time director of Tianjin Institute of Pharmaceutical Research Co., Ltd., part-time supervisor of Tianjin Lisheng Pharmaceutical Co., Ltd.

Former Deputy Director of Asset Management Department in Tianjin Tsinlien Investment Holdings Limited., Tsinlien Group Limited. and Tianjin Development Holdings Limited. General Manager of Tsinlien Horologia Company Limited.

Master of Management in Business School of  Nankai University.

Hua Liang  Director

Current managing director of China Merchants Capital Investment Limited.

Former executive director of China Merchants No. 1 Equity Investment Management Co., Ltd., Vice President of China Merchants Kunlun Equity Investment Management Co., Ltd., R&D manager of HP China, founding partner and Vice-general Manager of Beijing Yuheng Irida Technology Co., Ltd., Vice-general Manager of Embedded Systems Division in CS&S R&D Department.

International MBA of Peking University, Bachelor of Computer in University of Science & Technology Beijing.

Peng Jia  Board Secretary

Management

Changjiang Huang   Vice-general Manager

Expert with special allowance of the State Council

Part-time director of Tianjin Key Laboratory of New Drug Design and Discovery, director of Tianjin Institute of Pharmaceutical Research Innovation Drug Research Center.

Former vice director of Tianjin Key Laboratory of New Drug Design and Discovery, vice director of Tianjin Institute of Pharmaceutical Research Innovation Drug Research Center.

Doctorate of Applied Chemistry in School of Chemical Engineering and Technology, Tianjin University.

Peng Jia   Board Secretary and Vice-general Manager

Investment director of Health Industry Division in China Merchants Group. Former investment director of CR Healthcare Group, director of CR Healthcare Science & Technology (Beijing) Co., Ltd., Senior International Manager of Sinopharm. Former worker of State Administration of Traditional Chinese Medicine, State-owned Assets Supervision and Administration Commission of the State Council and Anhui Huaibei Mine Worker Hospital Group.

Doctoral candidate of Department of Political and Public Administration, University of Hong Kong (in progress), International MBA of Peking University, Master of Medicine Information Management in China Academy of Chinese Medical Sciences, Bachelor of Medicine in Chengdu University of TCM.

Hua Chen   Vice-general Manager

Part-time general manager of Tianjin Taipu Pharmaceutical Co., Ltd.

Former Vice-general Manager of Tianjin Taipu Pharmaceutical Technology Development Co., Ltd.

Bachelor of Chemical Medicine in East China University of Science and Technology.

Yinghai Bai   CFO

Chartered financial analyst

Former partner of DNV Capital, director of Direct Investment Department in Minyin Capital, managing director of Great Wall PAN Asia International Asset Management Co., Ltd., Chief Financial Officer of China Resources Holdings and its subsidiaries, CFO of Kunshan Hospital. Former worker of Ministry of Commerce of China and its subordinate body, Minmetals Hong Kong Financial Company, etc.

Master of Finance in London Business School, MBA in Tsinghua University, Bachelor of Economics in University of International Business and Economics.

Weiren Xu   Chief Engineer

Expert with special allowance of the State Council

Part-time director of Tianjin Institute of Pharmaceutical Research Project Management Center.

Former director of Tianjin Institute of Pharmaceutical Research Drug Innovation Research Centre, vice director of Tianjin Institute of Pharmaceutical Research Pharmacology Laboratory.

Doctorate in Physical Chemistry of School of Chemistry and Chemical Engineering, Shandong University.

Senior Consultant

Ke Ma   Vice-general Manager

Former vice president of Tianjin Institute of Pharmaceutical Research, general manager of Tianjin Institute of Pharmaceutical Research Pharmaceutical Co., Ltd.

Master and Bachelor of Applied Chemistry in Tianjin University.

Scientists

Chang-xiao LIU, honorary president of Tianjin Institute of Pharmaceutical Research (TIPR) 

Prof. Changxiao LIU, Fellow of Chinese Academy of Engineering. Prof. Liu graduated from Beijing Medical School (also known as Medical Department of Peking University) in 1965. Shortly after graduation, he joined Beijing Institute of Pharmaceutical Sciences. He worked as visiting scholar at Lunds Universitet (English: Lund University, Sweden) during 1986-1987 and was promoted to Professor at early of 1990s. Prof. Liu is the tenured chief scientist, and currently the honorary president of TIPR, also chairs the academic committee of Tianjn Institute of Pharmaceutical Research and is director of State Key Laboratory of Drug Delivery Technology and Pharmacokinetics. In addition, Prof. LIU acts as advisor of Chinese Pharmacopoeia Commission, executive director of Chinese Pharmaceutical Association, chair of Tianjin Pharmaceutical Society and Tianjin Regulatory Science Society, as well as China office director of ISSX. Prof. LIU has been appointed as guest professor/doctoral supervisor of China Pharmaceutical University, Shenyang Pharmaceutical University, Tianjin University, and other higher education institutes. Prof. LIU was nominated and awarded as “exemplar workers in the prevention and treatment of schistosomiasis in Hunan Province in1978”, “Experts on special allowances of the State Council in 1992”, “Tianjin exemplar worker in 2000”, “National exemplar worker in 2005”, “National outstanding science and technology workers in 2013”, “Hong Kong Bauhinia Medical Achievement Award and Gold Award for Medical Innovation in 2000”, “Thai Medicine Golden Elephant Award in 2000”, “German Medical Paper Award in 2000”, “Special Contribution Award of CPA in 2017”, “Special Contribution Award of ISSX in 2014”, “Life Achievement Award of WTCMS in 2018”, and “Life Achievement Award of Evidence-based TCM in 2020”.

Prof. Liu dedicated his life to pharmacology, particularly in pharmacokinetics field. He established the first specific laboratory for pharmacokinetics study in 1968. In 1975, pharmacokinetics was applied to review and assess new drug by Prof. Liu. The concept of pharmacokinetics was initially introduced to public and academia in China in 1980. In addition, He established the first Provincial Laboratory of pharmacokinetics in 1995 and State Key Laboratory of Pharmacokinetics in 2005. Concept of Model optimization, Automation and Batch processing have been proposed in “Practical program for pharmacokinetics” and been widely applied in pharmacokinetic studies, which has been extensively cited by over 9700 papers and applications up to date.

For the past 50 years, Prof. Liu has published over 400 peer-reviewed papers and 30 academic books. Prof. LIU has completed over 50 basic research projects funded either by central or local authorities, as well as over 150 drug development projects. The team led by Prof. LIU has been awarded over 40 Science and Technology Awards.

Prof. LIU has long been engaged in and dedicated to pharmacokinetics, drug evaluation, modernization of TCM, as well as strategy of biomedication.

   

Dianzhen Zhang, graduated from Chemistry Department of Nankai University in 1969, is the former new drug review expert of National Medical Products Administration, committee member of CPA Pharmaceutical Chemistry Committee, editorial board member of Chinese Journal of Medicinal Chemistry, member of World Hypertension League (WHL), member of Tianjin Institute of Pharmaceutical Research Academic Committee, member of Evaluation Committee of Professional Titles and New Drug Fund Review Committee, general manager of Tianjin Taipu Technology.

He has successively assumed the scientific research projects in the “seventh five-year plan”, the “eighth five-year plan” and the “ninth five-year plan”, chaired multiple new drug research projects, and successfully developed a batch of products with huge market, high technology difficulties and outstanding efficacies (indapamide, argatroban, adefovir dipivoxil, dezocine). He won multiple science and technology awards, such as Second Prize for Scientific and Technological Progress in Tianjin, Third Prize of Excellent Industrial Cooperation in Tianjin, PLA Third Prize for Scientific and Technological Progress, National First Prize for Outstanding Books, Certificate of Major Achievements in Science and Technology in the “seventh five-year plan”, Certificate of Major Achievements in Science and Technology in the “eighth five-year plan”, etc. He won many honorary titles, such as expert with special allowance of the State Council, National Advanced Medical Science and Technology Worker, Excellent Team Leader in National Pharmaceutical Industry System, Advanced Individual in Science and Technology Research in the “eighth five-year plan”, “May lst Labour Medal” in Tianjin, Outstanding Contributor to Science and Technology in Tianjin, Advanced Individual in the “15th Five-year Plan” of Tianjin, etc. He has published more than 40 papers in domestic journals and national academic conferences, and made great contributions to the development of medical research in our institute and Tianjin.

Lida Tang, secretary of the party committee, Deputy Chairman, chief scientist and researcher of Tianjin Institute of Pharmaceutical Research. Born in November 1963, he is the Bachelor of Biochemistry in Sun Yat-sen University, Master of Pharmacology in Academy of Military Medical Sciences, PhD in Chemistry of Shandong University, visiting scholar of University of California, Berkeley, Pharmacology Expert, Doctoral Supervisor and expert with special government allowance. Chaired more than ten national and provincial programs of National Natural Science Foundation of China, major new drug project, etc.; Completed the pharmacological research of more than 30 new drugs (cefdinir, compound Danshen dripping pills, etc.); Won more than 30 new drug certificates; Won six awards (Second Prize of National Science and Technology Progress Award, First Prize for Scientific and Technological Progress in Tianjin, Second Prize in Science and Technology CPA, etc.); Published more than 50 papers on domestic and foreign academic journals, participated in the preparation of 3 academic monographs; Applied for more than 60 invention patents.

Tiejun Zhang, chief expert and researcher of TCM Research and Development Centre in Tianjin Institute of Pharmaceutical Research. Expert with special allowance of the State Council, commissioned expert in Tianjin, national excellent science and technology worker. Member of CPA Specialized Committee on TCM and Natural Medicines; Vice president of WFCMS Professional Committee on New Drug Delivery Systems; Standing committee member of CSNR Professional Committee on Traditional Chinese Medicine Resources; Editorial board member of Acta Pharmaceutica Sinica, and Chinese Traditional and Herbal Drugs.
Engaged in R&D of new TCM, TCM quality control and secondary development of TCM species. Undertook 35 National and Tianjin Science and Technology Projects; Responsible for R&D of more than 20 TCM drugs and won 4 new drug certificates. Won more than 40 national invention patents; Edited 11 academic works, participated in the preparation of 13 works and published more than 300 papers. Won the first prize for scientific progress in National Administration of Traditional Chinese Medicine; Won the First Prize for Scientific and Technological Progress in Tianjin and two Second Prizes for Scientific and Technological Progress in Tianjin; Won First Prize for Scientific and Technological Progress in Anhui Province; Won Third Prize for Science and Technology in CPA.

To be the top R&D engine BigPharma in China
influencing the whole world